FilingReader Intelligence

CSPC Innovation swings to loss despite revenue growth

August 15, 2025 at 01:09 PM UTCBy FilingReader AI

CSPC Innovation Pharmaceutical reported operating revenue of RMB1.05 billion for the six months ended June 30, 2025, up 7.99% from the prior year.

However, net profit attributable to shareholders declined 102%, resulting in a loss of RMB2.7 million. Earnings per share fell 102.05% to -RMB0.0020.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when CSPC Pharmaceutical Group publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →